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The RNA exosome is a conserved degradation machinery, which obtains full 
activity only when associated with co-factors. The most prominent activator of 
the yeast nuclear exosome is the RNA helicase Mtr4p, acting in the context of 
the Trf4p/Air2p/Mtr4p polyadenylation (TRAMP) complex. The existence of 
similar activator(s) in humans remains elusive. By establishing an interaction 
network of the human nuclear exosome, we identify the trimeric Nuclear 
EXosome Targeting (NEXT) complex, containing hMTR4, the Zn-knuckle 
protein ZCCHC8 and the putative RNA binding protein RBM7. ZCCHC8 and 
RBM7 are excluded from nucleoli and consistently, NEXT is specifically 
required for the exosomal degradation of promoter-upstream transcripts 
(PROMPTs). We also detect putative homologues TRAMP subunits hTRF4-2 
(Trf4p) and ZCCHC7 (Air2p) in hRRP6 and hMTR4 precipitates. However, at 
least ZCCHC7 function is restricted to nucleoli. Our results suggest that human 
nuclear exosome degradation pathways comprise modules of spatially 
organized co-factors that diverge from the yeast model. 
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Introduction 
 
Cells rely on processing and turnover pathways to control their steady-state RNA 
levels. In addition, the efficient elimination of malformed molecules and 
transcriptional by-products is constantly required, demanding a subset of robust 
nucleases. The major eukaryotic 3’-5’ exonucleolytic activity is supplied by the multi-
subunit RNA exosome complex. It resides in both cytoplasmic and nuclear 
compartments and participates in a wealth of reactions, including the processing of 
rRNA, snoRNA and snRNA, the turnover of mRNA and the surveillance of most 
cellular RNA species (for recent reviews see (Houseley and Tollervey, 2009; Lykke-
Andersen et al., 2009)).  
First discovered in the yeast Saccharomyces cerevisiae, the exosome consists of 
a catalytically inactive nine-subunit core, that obtains its ribonucleolytic activity from 
associated subunits. These include the nuclear/cytoplasmic and processive 3’-5’ 
exo/endo-nuclease Dis3p/Rrp44p as well as the nuclear-specific and distributive 3’-5’ 
exonuclease Rrp6p (Allmang et al., 1999; Mitchell et al., 1997). Although active in 
vitro, the exosome needs appropriate activators and adapters for full function in vivo. 
While activators are integral to exosome activity, adapters may rather direct the 
exosome to its many substrates and therefore be particular to discrete 
processing/degradation pathways or even recognize specific RNA features. 
However, as activators and adapters often co-appear in larger complexes, a clear 
biochemical distinction between the two is difficult to make. Central for exosome 
activation is an associated RNA helicase activity. In the yeast cytoplasm, this task is 
performed by the Ski2p DEVH ATPase in the context of the trimeric SKI complex 
(Anderson and Parker, 1998; Brown et al., 2000), while the DExH/D box RNA 
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helicase Mtr4p is an essential activator of the yeast nuclear exosome (Allmang et al., 
1999; de la Cruz et al., 1998). Several Mtr4p activities are carried out in the context 
of the TRAMP complex, co-composed of one of the two non-canonical poly(A) 
polymerases, Trf4p or Trf5p, and one of the two Zn-knuckle proteins, Air1p or Air2p 
(LaCava et al., 2005; San Paolo et al., 2009; Wyers et al., 2005). TRAMP is 
suggested to target RNA, presumably through Air1p/Air2p, and trigger its 
processing/degradation via the 3’end-addition of an unstructured oligo(A) tail, 
enabling substrate unwinding by Mtr4p in preparation for exosomal nucleolysis. 
Interestingly, although Trf4p and Trf5p are close homologs and partially redundant 
(Houseley and Tollervey, 2006), Trf5p activity reportedly occurs in the yeast 
nucleolus, while Trf4p substrates are often non-nucleolar (Dez et al., 2007; 
Rougemaille et al., 2007; Wery et al., 2009; Wyers et al., 2005). Thus, exosome co-
activator composition is not only different between the yeast nucleus and cytoplasm, 
but also inside the nucleus between the nucleolus and the remainder of the 
nucleoplasm. The mechanistic rationale for such division is not clear. Regardless, as 
a reflection of its broad nuclear localization, tRNA, sn/snoRNA, pre-rRNAs, aberrant 
mRNA and a class of non-coding cryptic unstable transcripts (CUTs) are all TRAMP-
dependent exosome substrates (Allmang et al., 1999; Milligan et al., 2005; Reis and 
Campbell, 2007; van Hoof et al., 2000). In addition to TRAMP, the nuclear exosome 
co-operates with additional RNA binding proteins, which are currently best described 
as exosome/RNA adapters; (i) Rrp47p binds structured RNA substrates, associates 
with Rrp6p and is needed for Rrp6p-dependent exosome activities (Mitchell et al., 
2003; Stead et al., 2007), (ii) Mpp6p binds poly(U) RNA, is genetically linked to 
Rrp47p/Rrp6p and is important for many nuclear exosome activities (Milligan et al., 
2008), and (iii) the Nrd1p, Nab3p and Sen1p proteins associate with RNA 
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polymerase II and nascent RNA to recruit the nuclear exosome and TRAMP to 
process or completely degrade short transcripts, snoRNAs and CUTs, respectively 
(Vasiljeva and Buratowski, 2006). Moreover, the Nrd1p/Nab3p/Sen1p complex 
targets some RNA polymerase III transcripts, such as hypomodified, unedited or 
unspliced tRNAs (Wlotzka et al., 2011). 
The human RNA exosome also exists in cytoplasmic and nuclear forms, that 
share the highly conserved nine-subunit core. However, unlike in yeast, where Dis3p 
is the only processive exonuclease component, two Dis3p homologs have been 
found to associate with the human exosome core: hDIS3 present mainly in the 
nucleus and hDIS3L restricted to the cytoplasm (Tomecki et al., 2010). While nuclear 
hDIS3 appears largely excluded from nucleoli, the third exosome-associated 
nuclease, hRRP6 (PM/Scl100), accumulates in nucleoli, although it can also be 
detected in the non-nucleolar part of the nucleoplasm and to a minor extent in the 
cytoplasm (Lejeune et al., 2003; Staals et al., 2010; Tomecki et al., 2010). This 
differential composition and localization of exosome variants is also reflected by the 
substrate preferences of the complex in vivo (Lykke-Andersen et al., 2011).  
Much less is known about human exosome activators/adapters. Functional 
homologs of Rrp47p (C1D), Mpp6p (hMPP6) and Mtr4p (hMTR4, also called 
SKIV2L2) have been identified and suggested to help recruit the nuclear exosome to 
its substrates (Milligan et al., 2008; Schilders and Pruijn, 2008; Schilders et al., 2007; 
Tomecki et al., 2010). However, mechanistic detail is still lacking. Moreover, clear 
experimental evidence of TRAMP-like complexes outside of S. cerevisiae and S. 
pombe has not been obtained, despite the fact that at the sequence level this 
complex appears well conserved in e.g. T. brucei (Cristodero and Clayton, 2007; 
Etheridge et al., 2009) and D. melanogaster (Nakamura et al., 2008). Also in human 
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cells, candidate TRAMP components, in addition to hMTR4, are present; the closest 
homologs of Trf4/5p are hTRF4-1 (POLS) and hTRF4-2 (PAPD5). The latter was 
recently found to contribute to the 3’end adenylation of RNA polymerase I transcripts 
targeted by the exosome (Shcherbik et al., 2010). However, this is the only direct 
example of adenylation potentially being part of an RNA decay mechanism in 
Metazoa. Finally, the Zn-knuckle protein ZCCHC7 has been suggested to be a 
candidate Air1p/Air2p sequence homolog (Houseley and Tollervey, 2008). 
Here we use co-immunoprecipitation (co-IP) analyses of human nuclear exosome 
complexes coupled to high resolution mass spectrometry (MS) to discover a stable 
trimer, which we coin the Nuclear EXosome Targeting (NEXT) complex. NEXT 
contains hMTR4, the putative RNA binding protein RBM7 and the Zn-knuckle protein 
ZCCHC8. RBM7 and ZCCHC8 are excluded from nucleoli and their depletion leads 
to the selective stabilization of promoter upstream transcripts (PROMPTs). We also 
detect hTRF4-2 and ZCCHC7 in hRRP6/hMTR4 precipitates, and consistent with 
their nucleolar localization, these factors impact the 3’adenylation of rRNA 
degradation products. Our results identify new human exosome co-factors, 
demonstrate their differential nuclear partitioning and show a surprising divergence 
from the S. cerevisiae system. 
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Results 
 
hMTR4 association with the nuclear exosome is stabilized by hRRP6 
We previously reported that three nucleolytic subunits, hRRP6, hDIS3 and hDIS3L, 
associate with the human core exosome (Tomecki et al., 2010). Of these, hRRP6 
and hDIS3 mainly localize to the nucleus. Moreover, exosome binding under the 
employed purification scheme was more robust for hRRP6. Therefore, in order to 
investigate the protein-protein interaction network of the human nuclear exosome, we 
first used hRRP6 as the bait in co-IP experiments. To this end, a Flp-In T-Rex 
HEK293 cell line stably expressing a tetracycline (tet) inducible and C-terminally 
FLAG-tagged version of hRRP6 was constructed. Specific hRRP6 interaction 
partners were determined using stable isotope labeling in cell culture (SILAC) 
methodology (Ong et al., 2003), followed by hRRP6-FLAG co-IP and high-resolution 
MS analysis. Induction conditions leading to only modest hRRP6 overexpression and 
the presence of the bait protein in the FLAG IP eluate were verified by western 
blotting analysis (Fig. S1A). To minimize RNA-dependent interactions, hRRP6-, and 
all other subsequent, purifications were conducted in the presence of RNase A. 
The SILAC/MS approach classifies interactors by specificity (the SILAC ratio 
between peptide intensities of the bait-induced vs. un-induced samples) and protein 
abundance estimated from the sum of peptide signal intensities of a given protein 
normalized to its molecular mass (Fig. 1A). As expected, hRRP6 co-purified all nine 
core subunits of the exosome as well as C1D, hMPP6 and hMTR4 (Fig. 1A, 1B; 
Table S1). Also, in agreement with previous results, a less abundant - but highly 
specific - association of hDIS3 was detected. Interestingly, besides hMTR4, two other 
putative homologs of yeast TRAMP components, hTRF4-2 and ZCCHC7, were 
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identified, along with nucleolar WD40-proteins, with high SILAC ratios (Fig. 1A; Table 
S1) (Gallenberger et al., 2010; McMahon et al., 2010). This implies the existence of a 
human counterpart of yeast TRAMP (see below).  
hMTR4 has previously been reported to interact with the exosome only by indirect 
studies (Schilders et al., 2007; Tomecki et al., 2010). Our MS data demonstrated 
hMTR4 co-purification with hRRP6-FLAG to near stoichiometric levels (Fig. 1A; Table 
S1), a salt-sensitive affinity, which was also evident from commassie-stained protein 
gels of the hRRP6-FLAG eluate (Fig. 1B). To investigate whether hRRP6 help 
facilitate hMTR4 interaction with the nuclear exosome, we conducted core 
component (hRRP41-FLAG) co-IP analysis from HEK293 cells in which hRRP6 had 
been depleted by RNAi (Fig. S1B), and compared it to a co-IP from control siRNA-
treated cells. Upon hRRP6 siRNA administration, levels of the protein in the eluate, 
as determined by MS, dropped to ≈30% of that of exosome core components (Fig. 
1C). This drop was paralleled by a decrease in hMTR4 (Fig. 1C). In addition, levels of 
other exosome co-factors decreased (MPP6), or completely disappeared (C1D), 
concomitantly. Thus, hRRP6 appears to stabilize the association of hMTR4, as well 
as C1D and MPP6, with the exosome core (see Discussion). We note, however, that 
under physiological conditions, hMTR4 is likely able to interact/activate the exosome 
core hRRP6-independently. This is because hMTR4, but not hRRP6, is central for 
proper 5.8S rRNA 3’end processing ((Schilders et al., 2007); and see below). 
 
Identification of the hMTR4-containing NEXT complex 
Given its strong interaction with the nuclear exosome and its predicted central 
position as an exosome activator, we next characterized hMTR4 interaction partners 
by the SILAC/MS approach. To this end, physiological levels of hMTR4-FLAG was 
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stably expressed, and the presence of the bait protein in the FLAG IP was evaluated 
(Fig. S1C). In a SILAC experimental approach, the hMTR4-FLAG bait efficiently co-
purified the entire nuclear exosome core as well as hRRP6, C1D and MPP6 (Fig. 2A; 
Table S2). Interestingly, the hMTR4-FLAG co-IP disclosed a set of new and highly 
specific interaction partners harboring putative RNA recognition motifs, while hTRF4-
2 and ZCCHC7 only became detectable upon increasing the scale of the experiment 
in a label-free setting (Fig. S1D; Table S3, see Materials and Methods). Some of 
these new interaction partners were previously localized to the nucleus: ZCCHC8, 
RBM7, ARS2 and CBP80 (Gruber et al., 2009; Gustafson et al., 2005; Nielsen et al., 
2009; Wilson et al., 2008), whereas others are uncharacterized proteins, seemingly 
differentially localized between the non-nucleolar: ZC3H18 and C14orf102, and the 
nucleolar: ZFC3H1 and ZCCHC7, part of the nucleus (www.uniprot.org, 
www.lamondlab.com).  
To uncover the more stably associated factors, we first measured protein IP levels 
after extracts from induced and un-induced samples were mixed (mixed extract ‘ME’) 
prior to the IP reaction, and compared it to IP levels obtained using the normal 
procedure of mixing FLAG-affinity beads (mixed beads ‘MB’) before co-elution (Fig. 
2B). Since extract mixing allows for the exchange of labeled and non-labeled 
proteins, this experimental strategy assays the stability of interactions. Indeed, while 
hMTR4 association with nuclear exosome components was efficiently exchanged by 
the ME procedure, the RBM7, ZFC3H1 and ZCCHC8 proteins all purified with similar 
efficiencies whether the ME or the MB approach was applied (Fig. 2C). As hMTR4 
co-purified ZCCHC8 with very high specificity and protein abundance (Fig. 2A), we 
also assayed complex formation by a reverse co-IP experiment, employing HEK293 
cells stably expressing ZCCHC8-FLAG at physiological levels as the bait (Fig. S1E). 
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Gratifyingly, in addition to the entire nuclear exosome, MPP6 and C1D, ZCCHC8 
also co-purified hMTR4 and RBM7; both with a very high efficiency and specificity 
(Fig. 2D and S1F; Tables S4 and S5). Moreover, analysis revealed that while 
exosome components could be ‘chased’ by mixing extracts, the association of 
ZCCHC8 with hMTR4 and RBM7 remained unaffected (Fig. 2E). Consistently, 
conducting hMTR4-FLAG or ZCCHC8-FLAG purifications at stringent conditions of 
500mM NaCl resulted in the specific enrichment of hMTR4/ZCCHC8/RBM7 trimeric 
complexes (Fig. S2A and S2B; Table S6 and S7). Finally, we performed purification 
of a stably integrated RBM7-EGFP fusion construct, which revealed a near 
stoichiometric interaction with hMTR4 and ZCCHC8 (Fig. 2F). Collectively, these 
analyses demonstrate that hMTR4, ZCCHC8 and RBM7 form a stable trimeric 
complex, which we have named the Nuclear EXosome Targeting (NEXT) complex. 
 
Sub-nuclear partitioning of exosome co-factors 
To complement the proteomic analyses, we next examined the subcellular 
localization of NEXT components, and also included hTRF4-2 and ZCCHC7 in this 
analysis. Both N- and C-terminal EGFP fusions were generated and visualized by 
confocal microscopy in transiently transfected HeLa- and in stably transfected 
HEK293-cells, respectively. Generally, the positioning of the EGFP-tag did not affect 
localization of factors. Noticeably, ZCCHC8 and RBM7 both localized strictly to the 
non-nucleolar part of HeLa and HEK293 nuclei (Fig. 3A, 3B and S3A). Moreover, a 
revisit of the distribution of hMTR4 confirmed its previously reported nuclear 
localization with nucleolar accumulation, resembling the distributions of hRRP6, 
MPP6 and C1D (Schilders et al., 2007; Tomecki et al., 2010). Taken together with 
the co-IP analyses, we therefore suggest that the non-nucleolar pool of hMTR4 
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associates with ZCCHC8 and RBM7 to form the NEXT complex, whereas nucleolar 
hMTR4 is, among other factors, complexed with hRRP6, MPP6 and C1D. 
Turning to putative TRAMP homologs, a remarkably strict nucleolar localization of 
ZCCHC7 was observed (Fig. 3A, 3B, and S3A). This result was confirmed using anti-
ZCCHC7 antibodies for immuno-localization analysis of HeLa cells, a signal which 
disappeared upon depletion of the ZCCHC7 protein by RNAi (Fig. S3B). The 
nucleolar localization of ZCCHC7 is consistent with its association with factors 
previously reported to be nucleolar (see below). Finally, examination of hTRF4-2-
EGFP expressing cells demonstrated its nuclear localization with nucleolar 
accumulation, fairly similar to hMTR4 (Fig. 3A, 3B, and S3A). This finding is 
consistent with localization data obtained for the closest Trf4/5p homolog in fission 
yeast, Cid14, and for DmTrf4 in D. melanogaster (Nakamura et al., 2008; Win et al., 
2006). It is also compatible with the recent finding that hTRF4-2 is involved in the 
adenylation of rRNA degradation products (Shcherbik et al., 2010), but contrasts the 
unexpected cytoplasmic localization previously reported (Mullen and Marzluff, 2008). 
To further characterize these putative nuclear exosome co-factors, we determined 
their sedimentation profiles in a 5%-40% glycerol gradient, separating whole cell 
extracts of HEK293 cells. Individual fractions of the gradient were subsequently 
analyzed by western blotting using available antibodies. The human exosome core 
has previously been reported to sediment into two differently sized pools (Mitchell et 
al., 1997; van Dijk et al., 2007), which we also found by probing fractions with 
hRRP40 and hRRP45 antibodies (Fig. 3C). Interestingly, hDIS3 was virtually 
excluded from the high molecular weight portion of the gradient, where instead 
hRRP6 accumulated. In contrast, hDIS3 was found in the light fractions, where 
hRRP6 was relatively less present. This rough separation of nuclear exosome sub-
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populations parallels well the nucleolar exclusion and accumulation of hDIS3 and 
hRRP6, respectively (Tomecki et al., 2010). A similar partitioning of ZCCHC8 and 
ZCCHC7 was observed, with the former primarily present in the hDIS3 containing 
fractions, and the latter accumulating in the hRRP6 containing fractions (Fig. 3C). 
Again, this correlates well with the sub-nuclear localization of these factors. We were 
unable to probe the gradient fractions for RBM7 and hTRF4-2 as antibodies towards 
these factors were not available. 
 
Interaction profiles of human putative TRAMP homologs 
hMTR4, hTRF4-1, hTRF4-2 and ZCCHC7 display a domain composition similar to 
their putative yeast counterparts (Fig. 4A; for full alignments see Fig. S4A-C). Given 
their specific presence in the hRRP6-FLAG- and hMTR4-FLAG-precipitates (Fig. 1A 
and S1D), we focused on ZCCHC7 and hTRF4-2 for further label-free interaction 
studies. As in earlier purifications, moderate induction levels were used (Fig. S4D, 
lower left, ZCCHC7 was tested – for hTRF4-2 no antibodies were available) and the 
presence of bait proteins in the FLAG IPs was verified. The strongest indication of a 
human TRAMP complex comes from the ZCCHC7-FLAG bait purification, where 
hMTR4 and hTRF4-2 were specifically present in high amounts together with 
exosome components (Fig. 4B; Table S8). Moreover, in agreement with its 
localization, the ZCCHC7-FLAG IP revealed WDR36, WDR3, PWP2 and TBL3 
proteins that are involved in rRNA biogenesis (Gallenberger et al., 2010). These 
proteins were also present in the hTRF4-2-FLAG eluate, as was hRRP6, hMTR4 and 
ZCCHC7 (Fig. 4C and 4D; Table S9). In addition, hTRF4-2 also interacted with a 
subset of splicing factors. This dual interaction profile with assigned nucleolar and 
non-nucleolar proteins likely reflects the sub-nuclear localization of hTRF4-2 (Fig. 3).  
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Although the ZCCHC7 and hTRF4-2 interaction analysis indicated the presence 
of a human TRAMP complex, we were not able to obtain enough material to verify its 
existence by SDS-PAGE and protein staining. Instead, we conducted western 
blotting analysis and confirmed the co-IP/MS data that ZCCHC7 and hTRF4-2 
interact with each other and with hRRP6 in a salt-sensitive manner (Fig. 4D). 
 
Substrate preferences of human exosome co-factors reflect their sub-nuclear 
localizations (NEXT components) 
Provided that the proteins characterized in this paper are true co-factors of the 
human exosome, their removal should affect levels of its nuclear substrates. Hence, 
to examine the in vivo activity of NEXT components, hTRF4-2 and ZCCHC7, we 
depleted these proteins in HeLa cells using RNAi (Fig. 5A). In the case of RBM7 and 
hTRF4-2 where antibodies were not available, we tested the siRNA-directed 
depletion efficiency on cell lines stably expressing RBM7-EGFP (Fig. 5A, bottom left) 
or hTRF4-2-FLAG (Fig. 5A, bottom right). All siRNAs exhibited robust knock down 
efficiencies. In addition, and as previously reported for the hRrp40 knock down, 
which co-depletes hRrp6 (Kammler et al., 2008; Tomecki et al., 2010), depletion of 
key proteins in some cases decreased levels of others; i.e. hMTR4 knock down co-
depleted ZCCHC8 and hRRP6 (Fig. 5A, lane 4) and administration of siRNA against 
hTRF4-2 caused decreased levels of ZCCHC7 (Fig. 5A, lane 3). This possibly 
reflects the tight individual interactions of these factors. 
As the NEXT complex is confined to the non-nucleolar part of the nucleus, we 
turned to PROMPTs (Preker et al., 2008). These transcripts are degraded by either 
of the two nuclear nucleolytic exosome subunits hRRP6 or hDIS3, the latter of which 
is excluded from nucleoli (Tomecki et al., 2010). We therefore surmised that 
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exosome-directed PROMPT-removal cannot be nucleolar. In agreement with 
previous studies (Preker et al., 2008; Tomecki et al., 2010), selected PROMPTs were 
markedly stabilized in hRRP40 singly- as well as hDIS3/hRRP6 double-depleted 
cells, whereas individual depletion of hDIS3 or hRRP6 had smaller effects (Fig. 5B). 
Interestingly, depletion of NEXT complex components also resulted in robust 
PROMPT stabilization, whereas hTRF4-2- and ZCCHC7-depletions had no effect. 
Increased PROMPT levels were most pronounced in hMTR4-depleted samples, 
probably reflecting the pleiotropic effects of this knock down. We conclude that the 
NEXT complex cooperates with the nuclear exosome to remove PROMPTs from the 
non-nucleolar parts of human cell nuclei. 
 
Substrate preferences of human exosome co-factors reflect their sub-nuclear 
localizations (ZCCHC7 and hTRF4-2) 
Due to the nucleolar localizations of ZCCHC7 and hTRF4-2, we next turned to 
substrates assumed to be degraded in this sub-compartment. hTRF4-2 is involved in 
the adenylation of nascent 47S rRNA degradation intermediates (Fig. 6A), appearing 
as a result of treatment with a low concentration of Actinomycin D (Shcherbik et al., 
2010). Presumably the drug triggers rRNA degradation by inhibiting RNA polymerase 
I activity, and since this is the hallmark of nucleolar assembly, we inferred that 
hTRF4-2 action may occur herein. To visualize adenylation of these pre-rRNA 
degradation intermediates, we adopted the assay of Shcherbik et al. and subjected 
total RNA from Actinomycin D treated cells to dT-primed semi-quantitative PCR 
followed by Southern blotting analysis using a radio-labeled 5'ETS specific probe 
(Fig. 6B). In accordance with published data, depletion of hRRP40 or hRRP6 
resulted in increased levels of PCR products corresponding to adenylated 5'ETS 
 15 
fragments, as did hMTR4-depletion (Fig. 6C). hDIS3 knockdown had no effect, 
implying that 5’ETS adenylation is indeed occurring in the nucleolus. Importantly, 
depletion of both hTRF4-2 and ZCCHC7 resulted in decreased levels of 5’ETS 
product as compared to the EGFP control (Fig. 6C, compare lane 1 with lanes 6 and 
9), whereas ZCCHC8 and RBM7 depletions had no effect. Even more pronounced, 
co-depletion of hTRF4-2 or ZCCHC7 in the hRRP40- or hMTR4-depleted 
backgrounds, yielded a substantial down-regulation of the otherwise increased 5’ETS 
signals (Fig. 6C, compare lane 2 with lanes 7 and 10, or lane 5 with lanes 8 and 11). 
We conclude that ZCCHC7 and hTRF4-2 are co-factors of the human nucleolar 
exosome and that although ZCCHC7 has no adenylation activity of its own, it 
possibly aids hTRF4-2 in this function. Moreover, hMTR4 appears dispensable for 
adenylation of 5'ETS fragments, suggesting that a putative hTRF4-2/ZCCHC7 dimer 
may suffice to bind and adenylate target RNA, whereas hMTR4 facilitates recruitment 
of the exosome for transcript degradation. 
Finally, we tested the effects of factor depletions on nuclear processing of the 
thoroughly studied exosome substrate 5.8S rRNA. As previously observed (Tomecki 
et al., 2010), hRRP40 and hRRP6/hDIS3 depletions caused the appearance of 
slower migrating 5.8S rRNA species when assayed by northern blotting analysis 
using a probe specific for the 3’extended region (Fig. 6D). Interestingly, hMTR4 
depletion also yielded a robust 3’end processing defect, while neither ZCCHC8, 
RBM7, hTRF4-2 nor ZCCHC7 knock down showed a noticeable phenotype. It 
therefore seems that 5.8S rRNA processing requires the nuclear exosome 
complexed with hMTR4, whereas the NEXT complex and the putative TRAMP 
homologous factors are dispensable. Moreover, the partial phenotype seen upon 
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hDIS3 depletion argues that 5.8S rRNA 3’end processing in human cells occurs - at 
least in part - outside nucleoli. 
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Discussion 
 
A vast amount of work on the S. cerevisiae exosome has convincingly demonstrated 
the need for co-factors to efficiently deal with its many cellular RNA substrates. Here, 
we uncover an interaction network of the human nuclear exosome, revealing a set of 
new partners, harboring an unanticipated complexity of composition and 
compartmentalization. Our data position hMTR4 as a central component in the 
coupling between the ribonucleolytic activity of the exosome and its other co-factors 
(summarized in Fig. 7). In sum, we propose that hRRP6 helps stabilize the tethering 
of hMTR4 to the exosome core, and that hMTR4 provides the link to compartment-
specific activators/adaptors. Thus, similar to the ribonucleolytic activities of the 
human exosome, its nuclear co-factor complexes are also differentially distributed 
(Staals et al., 2010; Tomecki et al., 2010). 
In S. cerevisiae, Mtr4p is indispensable for all known nuclear exosome activities, 
including 5.8S rRNA processing, which does not require other TRAMP complex 
components (Allmang et al., 1999; Bird et al., 2005; LaCava et al., 2005; Torchet et 
al., 2002; van Hoof et al., 2000). Our data suggest a parallel situation in human cells; 
i.e. depletion of hMTR4 causes, in contrast to other examined exosomal co-factors, 
an accumulation of 5.8S rRNA precursor species akin to that resulting from depletion 
of the hRRP40 core exosome subunit (Fig. 6C). Moreover, hMTR4 also exerts 
‘exosome core-like activity’ on the analyzed PROMPT and 5’ETS substrates (Fig. 5B 
and 6B). Taken together with our data, that hRRP6 co-purifies hMTR4 with the 
exosome core at near stoichiometric levels (Fig. 1A), it seems appropriate to 
consider hMTR4 an integral activator of the human nuclear exosome. In further 
support of this notion, the sub-nuclear distributions of hMTR4, hRRP6, and the core 
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component hRRP45 (PM/Scl-75) are strikingly similar (Schilders et al., 2007). We 
note that Mtr4p also co-purifies with Rrp6p in yeast, thus, making a similar scenario 
possible in this organism (Peng et al., 2003). It is unlikely, however, that in vivo 
hRRP6 is the only factor involved in the tethering of hMTR4 to the exosome core as 
in both yeast and human cells, hRRP6 depletion yields relatively mild phenotypes on 
some substrates, e.g. 5.8S rRNA, as compared to hMTR4- or exosome core 
component-depletion (Fig. 6D, (Allmang et al., 1999; de la Cruz et al., 1998; LaCava 
et al., 2005; Schilders et al., 2007)). Thus, hMTR4 may also be involved in preparing 
substrates for the exosome, independent of its direct association.  
 
The NEXT complex 
S. cerevisiae Mtr4p is in excess of other exosome components and co-factors 
(Ghaemmaghami et al., 2003). Our co-IP experiments suggest a similar situation in 
human cells; i.e. hMTR4 is purified by hRRP6-FLAG in stoichiometric amounts with 
exosome components (Fig. 1A), but is in excess over same factors when hMTR4-
FLAG is used as the bait (Fig. 2A). This may indeed enable hMTR4 to ‘explore’ the 
nucleus for additional co-factors, some of which are likely to serve as adaptors 
between the exosome and its substrates. Here, we describe the identification of the 
NEXT complex, consisting of hMTR4, ZCCHC8 and RBM7. This trimeric complex 
can be purified to near homogeneity at high salt conditions when RBM7-EGFP is 
used as the bait (Fig. 2F), and is very stable when challenged with exogenous extract 
in the ME/MB experimental scheme (Fig. 2C and 2E). NEXT factors also co-purify to 
near stoichiometry when physiological levels of ZCCHC8-FLAG are used as bait (Fig. 
2D). However, consistent with the idea that hMTR4 is also engaged with other 
exosome co-factors, with the exosome itself and perhaps even with exosome-
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unrelated proteins, RBM7 and ZCCHC8 are detected only as sub-stoichiometric 
partners when physiological levels of hMTR4-FLAG are used as bait (Fig. 2A). 
We suggest that NEXT constitutes a non-nucleolar hMTR4-containing complex 
(Fig. 7), which targets, among other possible substrates, PROMPTs for rapid 
exosomal turnover. This is because nuclear ZCCHC8 and RBM7 are excluded from 
nucleoli (Fig. 3), and because their depletions result in PROMPT stabilization levels, 
that are reminiscent of those obtained when depleting hRRP40 or hRRP6/hDIS3 
(Fig. 5B). Since RBM7 and ZCCHC8 harbor an RRM and a Zn-knuckle domain, 
respectively, it is possible that they provide substrate-targeting activity. Their tight 
assembly with hMTR4 in the NEXT complex could then facilitate the efficient 
funnelling of e.g. PROMPTs into the exosome. Such a model suggests the existence 
of a divergent pathway for nuclear ncRNA turnover in higher eukaryotes. As 
PROMPTs share many characteristics with S. cerevisiae CUTs, the participation of 
putative TRAMP homologs in PROMPT decay might have been expected. However, 
ZCCHC7 depletion has no discernable effect on PROMPT levels (Fig. 5B). Moreover, 
although hTRF4-2 can adenylate PROMPT 3'ends (Preker et al., submitted), this 
activity is not required for RNA degradation per se (Fig. 5B). Rather, PROMPT 
3’ends, accumulating in the absence of a functional exosome, can provide substrates 
for hTRF4-2, consistent with its presence also in the non-nucleolar part of the 
nucleus. This is in contrast to S. cerevisiae, where both Trf4p and Air2p are directly 
required for the decay of CUTs (Wyers et al., 2005). Another difference between 
systems is the apparent lack of a human Nrd1p/Nab3p/Sen1p complex, which 
couples the transcription termination of CUTs to their rapid turnover (Lykke-Andersen 
and Jensen, 2006). Based on sequences, there are no strong candidate homologs of 
Nrd1p and Nab3p in the human genome. It thus remains an open question how 
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tightly the NEXT-directed decay of PROMPTs is coupled to the act of PROMPT 
transcription. As most human snoRNAs are cleaved out of larger precursor RNAs, in 
contrast to S. cerevisiae snoRNAs that are often transcribed from independent loci, it 
may be that the requirement of a Nrd1p/Nab3p/Sen1p-like complex to couple ncRNA 
transcription directly to exosomal processing/decay has been lost during evolution. 
Interestingly, ZCCHC8 was previously found to be a target of the glycogen 
synthase kinase 3 (GSK-3) and to co-purify RBM7 and hMTR4, although no link to 
the RNA exosome was made (Gustafson et al., 2005). Moreover, RBM7 reportedly 
interacts with splicing factors (Guo et al., 2003). The relevance of these observations 
for the role of NEXT in RNA biology and exosomal targeting remains to be 
addressed. 
 
A TRAMP complex in human cells? 
Much effort has gone into the identification of TRAMP subunit homologs in higher 
eukaryotes, but apart from predictions, only little experimental support has been 
provided (Houseley and Tollervey, 2008). Here, we identify for the first time putative 
human TRAMP subunits hTRF4-2 (PAPD5) and ZCCHC7 (hAIR2) using hRRP6 (Fig. 
1A) or hMTR4 (Fig. S1D) as purification baits. Validation by western blotting analysis 
verifies that these proteins indeed interact with the nuclear exosome and hMTR4, 
albeit less strongly than NEXT components (Fig. 4D). Consistently, hTRF4-2 is 
reportedly involved in the adenylation of rRNA degradation products (Shcherbik et 
al., 2010), an observation recapitulated in this paper and extended to also be valid for 
ZCCHC7 (Fig. 6C). As opposed to its assembly into the NEXT complex, we do not 
have firm proof that hMTR4 interacts directly with neither ZCCHC7 nor hTRF4-2. 
However, in favor of such a scenario, hMTR4 protein abundance was high in both 
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ZCCHC7-FLAG- and hTRF4-2-FLAG-IPs (Fig. 4B and 4C). Hence, we predict the 
existence of a nucleolar human ‘TRAMP-like’ complex (Fig. 7), which may even 
contain additional components like WDR3, WDR36, PWP2 and TBL3, scoring with 
similarly significant protein efficiencies in ZCCHC7-, hTRF4-2- and hMTR4-FLAG-
precipitations (Fig. 4B, 4C and Fig. S1D). The exact composition of such complex(es) 
awaits further characterization.  
Our reported nuclear localization of hTRF4-2 contrasts that reported by Mullen et 
al. (Mullen and Marzluff, 2008), who found the protein to be mainly cytoplasmic, a 
finding challenged by recent functional studies (Schmidt et al., 2010; Shcherbik et al., 
2010). The hTRF4-2 clone used in this study exhibits a higher degree of conservation 
when compared to other vertebrate genomes (see Materials and Methods), and 
fusing it to EGFP, yielded the presented localization. Moreover, the amino acid 
composition of this isoform is consistent with the hTRF4-2 peptides obtained from 
both the ZCCHC7- and hMTR4-co-IPs, and we note that our hTRF4-2 IP also yields 
factors that are consistent with a nuclear function. Taken together, this strongly 
suggests that the present clone expresses physiologically relevant hTRF4-2. The 
functional relevance of hTRF4-2 outside nucleoli remains to be investigated, but the 
consistent presence of splicing factors in the hTRF4-2 co-IP may link the protein to 
pre-mRNA biology. 
 
Additional targeting complexes of the nuclear human exosome? 
Our data imply that additional nuclear exosome co-factors may exist. Most 
prominently present in the hMTR4- and ZCCHC8-FLAG-IPs are the Zn-knuckle 
proteins ZFC3H1, ZC3H18 and ARS2 (Fig. 2A, Fig. 2D, Fig. S1D, Fig. S1F and Fig. 
S2A). Interestingly, ZFC3H1 scores high for both specificity and abundance in the 
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hMTR4 IP even when conducted in 500mM NaCl (Fig. S2A). ZC3H18 is significantly 
present in the ZCCHC8 IP (Fig. 2D), indicating a non-nucleolar localization. Future 
work will focus on delineating the nature of possible RNA substrates for these 
proteins. Finally, both hMTR4- and ZCCHC8-FLAG baits consistently co-purify the 
ARS2 protein together with one or both of the cap-binding proteins CBP20 and 
CBP80 (Fig. 2A, Fig. 2D, Fig. S1D and Fig.S1F). Murine and Drosophila ARS2 was 
recently suggested to link CBP20/CBP80 to the RNAi system, possibly through the 
biogenesis of miRNA (Gruber et al., 2009; Nielsen et al., 2009; Sabin et al., 2009; 
Wilson et al., 2008). Our finding may therefore link the human exosome with miRNA 
metabolism.  
The complexity and range of reported RNA exosome substrates have steadily 
increased since the first discovery of the S. cerevisiae complex (Mitchell et al., 1997). 
Most, if not all, nuclear RNA 3’ends have, at some physiological condition, a chance 
of encountering the exosome, posing the question how these substrates are targeted 
for processing or decay. Although the rules of such targeting as well as the 
mechanisms underlying exosome activation are not yet well understood, this work 
revealing a set of new co-factors should pave the way for such analysis in human 
cells. 
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Materials and Methods 
 
Plasmids and cloning 
Plasmids used in the study are listed in Table S10. Coding sequences were amplified 
by PCR from a HEK293 cDNA library using oligonucleotides listed in Table S11, and 
cloned into the BamHI/XhoI sites of pcDNA5/FRT/TO-FLAG (Invitrogen) using 
standard procedures . Tetracycline inducible cell lines stably expressing FLAG or 
EGFP fusions were generated according to the manufacturer using the Flp-In™ T-
REx™ system (Invitrogen). Optimal expression conditions were tested for each 
construct using different concentrations (10-1000ng/ml) of tetracycline. 
To amplify cDNA encoding hTRF4-2 HeLa- and HEK293-RNA was used. The 
longest cDNA variant was sub-cloned to obtain FLAG- and EGFP- protein fusions (as 
described above). In comparison to the previously localized isoform of hTRF4-2 
(Q8NDF8) (Mullen and Marzluff G&D 2008), the one used here (submitted to 
UniProt) includes two insertions: (i) 12 amino acids in close proximity to the signal 
peptide (N-terminus) and (ii) 47 amino acids in the C-terminal region of the protein. 
 
SILAC and label-free co-IPs 
In SILAC experiments proteins were labelled with stable isotopes in cell culture. 
HEK293 Flp-In T-Rex cell lines harbouring FLAG-tagged versions of hRRP6, 
ZCCHC8 or hMTR4 were cultured for a minimum of five doublings in custom-made 
DMEM SILAC media, containing 15% dialyzed FBS (Gibco), 2mM L-glutamine, 
100U/ml penicillin and 100ug/ml streptomycin. Subsequently, cells were grown for 
24h in media containing Lys0 (12C6
14N2) and Arg0 (
12C6
14N4), or Lys4: (
2H4) and Arg6 
(13C6
14N4) (Sigma-Isotec), fresh media was added and the pool of cells growing on 
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labelled amino acids was induced with tetracycline (hRRP6 – 30ng/ml, hMTR4 – 
30ng/ml, ZCCHC8 – 10ng/ml). 24h later, cells from one 145mm plate were collected 
and washed in 0,75ml of PBS (Gibco) and collected in RSB100 buffer (10mM 
Tris/HCl pH 7.4, 100mM NaCl, 2.5mM MgCl2), containing 0.5% Triton X100 and 
protease inhibitors (Roche). Cells were gently lysed by sonication: 3x10sek, 20W 
(Branson 250) and centrifuged (4000g, 15min) at 4C. Supernatants were treated 
with RNase A (100ug/ml) for 15min on ice and centrifuged (16000g, 5min) at 4C. 
‘Mixed extracts (ME)’ and ‘mixed beads (MB)’ experiments were set-up as described 
in the results section and loaded onto agarose anti-FLAG (M2) beads (Sigma). After 
3h of incubation, beads were washed 4 times with RSB100/0.5% Triton X100. For 
the MB approach, beads were pooled in one tube, and both MB and ME were 
washed 4 times with RSB100. For high-salt purifications all washing steps were 
performed in RSB500 (500mM NaCl). Proteins were eluted with FLAG peptide (0.5 
mg/ml) in TBS (Sambrook and Russell, 2001). Additional elution was done by 
incubation with 2 x SDS loading buffer. Before MS analyses samples were analysed 
SDS-PAGE followed by silver staining (data not shown) and western blotting. 1/100 
of the initial input and 1/10 of FLAG eluate, respectively, were loaded on gels. 
 
Sample preparation, MS analyses and data treatment 
Prior to MS analysis eluates were denatured with 8M Urea and digested in solution 
by endoproteinases: LysC in 6M Urea, 50 mM ammonium bicarbonate buffer, pH 7.8 
(0.1AU/mL, Wako) for 3h at room temperature and trypsin (Promega) over night at 
37C. Released peptides were reduced in 10mM dithiotreitol (DTT) for 30min at RT 
and alkalized in 55mM iodoacetamide for 20min at room temperature. Finally, 
peptides extracted with 1% trifluoroacetic acid (TFA) and concentrated on home-
 25 
made reverse-phase C18 columns (prewashed with methanol) were eluted with 80% 
acetonitrile/0.5% TFA, then dried and analyzed by LC-MS. 
MS and data analyses were performed as previously described (Tomecki, et al. 
2010). The LTQ-Orbitrap mass spectrometer was operated in a mode, which 
provides high-resolution of ion spectra (m/z 300–1500, resolution 60000 and ion 
accumulation to a target value of 5x106 ions). MaxQuant software (version 1.0.13.13) 
was used to extract peptide ion and fragment ion m/z intensity signals from the mass 
spectra (Cox and Mann, 2008), which were submitted to the Mascot program (Matrix 
Science) for database searches (Human IPI sequence database). The same 
software was used for calculation of peptide isotope ratios as well as evaluation of 
the certainty of peptide identification using false discovery rate analysis. 
Label free quantitation was done using the MaxQuant software. Peptide m/z 
signal intensity was found summing intensities over the entire elution of the peptide, 
and protein intensity as the sum of intensities for all peptides representing the 
protein. Proteins included in Tables S1-9 provide hits identified by a false discovery 
rate of 0.01 derived by decoy database searching, and only unique peptides were 
used for the quantitation. The previously reported non-specific binders also detected 
in a ‘bead proteome’ were removed from the datasets (Tomecki et al., 2010). 
 
Purification of the NEXT complex 
HEK293 RBM7-EGFP cells were induced by 10ng/ml of tetracycline. The standard 
co-IP protocol was scaled up to include ten 145mM plates and the entire procedure 
was performed in high salt conditions (RSB500). Elution was performed with 0.1M 
glycine pH 2.5, followed by neutralization with 1M Tris/HCl pH 8.0. 1/10 of the eluate 
was loaded on the gel. 
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Protein alignments and motif finding  
Protein sequences (Table S12) were loaded into the CLC Main workbench 5.6.1 
software (www.clcbio.com). Alignments were created using the create alignment tool 
with a gap open cost of 10 and a gap extension cost of 1. Protein motifs were found 
using the pfam domain search, using the 100 most common motifs and a significance 
cut-off at E=1. 
 
Localization studies 
Localization analyses were performed essentially as described (Tomecki et al., 
2010). For localization of EGFP-tagged proteins in HeLa cells, the cells were seeded 
on 6-well Lab-Tek® Chamber Slides (Nunc), and 12h later transfected with 
appropriate constructs using a standard transfection protocol. Test media was 
supplemented with tetracycline to induce protein expression. 24h later localization 
experiments were performed directly on living cells, or indirectly by 
immunofluorescence analysis of formaldehyde-fixed cells. Nuclei were stained with 
Hoechst 33342 and nucleoli were visualized by both phase contrast light and anti-
fibrillarin antibodies (Abcam 1:150). Cells were visualized by confocal microscopy - 
Olympus FluoView® FV10i – using a 60x water-immersion objective (NA 1,2). 
 
siRNA-mediated knock-downs and RT-qPCR 
Transfections were carried out using 20 nM siRNA (Table 13) for 2 days and 
repeated for another 2 days both times using Lipofectamin2000 (Invitrogen). Five μg 
of total RNA was treated with 1U of DNase I (Invitrogen), reverse transcribed using 
0.5μg of a dT primer, which was anchored at the 3’end and carried an adaptor at the 
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5’end (APVN) and Superscript II in a volume of 20μl. Dilutions were subjected to 
qPCR analyses on a Stratagene Mx3005P using Platinum SYBR Green (Invitrogen) 
and 0.3μM of oligonucleotides at an annealing temperature of 59°C. Controls lacking 
Superscript II showed a negligible background. A complete list of RT-qPCR primers 
is found in Table S14. 
 
Western blotting analysis 
Cells were treated with siRNA directed against the protein of interest and equal 
amounts of cell lysate, or whole cell extract, were subjected to 10% SDS PAGE, and 
subsequently analyzed according to standard procedures (Sambrook and Russell, 
2001) using the following primary antibodies: monoclonal mouse anti-FLAG M2 
(Sigma-Aldrich), polyclonal mouse anti-ZCCHC8 and polyclonal rabbit anti-hMTR4 
(Abcam), polyclonal mouse anti-RRP40 and anti-EGFP (Santa Cruz biotechnology), 
polyclonal rabbit anti-RRP40 (courtesy of Dr. Ger Pruijn), polyclonal rabbit anti-DIS3 
(Abnova), polyclonal anti-ACTIN and polyclonal rabbit anti-RRP6 (Sigma-Aldrich) and 
polyclonal rabbit anti-ZCCHC7 (Atlas antibodies). Anti-mouse and anti-rabbit IgGs 
coniugated with HRP (Dako) were used as secondary antibodies . 
 
Glycerol gradient 
Whole cell extracts were prepared by washing cells with PBS followed by scraping 
into RSB100 buffer, containing 0.5% Triton X-100 and protease inhibitor (one 
Complete, mini, EDTA-free, Protease Inhibitor cocktail (Roche) tablet per 10ml of 
buffer). Cell slurries were sonicated on ice using a Branson Sonifier 250 at setting 1 
(output: 20W) for 3x10 s, and subsequently centrifuged at 4000g for 15min at 4C. 
The supernatant was loaded onto a 5%-40% (v/v) glycerol gradient, prepared in 
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gradient buffer (RSB100 containing 0.5% Triton X-100). The gradient was centrifuged 
essentially as described (van Dijk et al., 2007), only using a SW41 (Beckman) rotor, 
and collecting 21 fractions. These were precipitated by TCA, re-suspended in SDS 
load buffer, separated by SDS-PAGE and transferred to a nitrocellulose membrane 
for western blotting analysis. 
 
rRNA analysis 
Five μg of total RNA from cells treated with siRNA was run on a 7% denaturing 
polyacrylamide gel and analyzed by standard northern blotting procedures. ITS2 
extensions and mature 5.8S rRNA were visualised using an in vitro transcribed RNA 
probe kindly provided by Dr. Ger Pruijn (Schilders et al., 2007) and a 5’radiolabeled 
5.8S rRNA specific DNA oligo: 5’-GTGTCGATGATCAATGTGTCCTGCAATTCA, 
respectively.  
To analyze 5’ETS degradation products, HeLa cells were treated with siRNAs as 
described above. Before harvest, the medium was replaced with RPMI containing 20 
ng/ml Actinomycin D for 60min. RNA was harvested and cDNA was prepared as 
described above, but using an unanchored adaptor-carrying dT primer (AP). The 
5’ETS region was amplified by 19 cycles of PCR, using a 5’ETS-specific forward 
primer and the Abridged Universal Amplification Primer (AUAP), containing the 
sequence of the adaptor. PCR products were run on a 1% agarose gel and analyzed 
by standard southern blot procedures using an internal probe against 5’ETS. PCR 
using primers designed to amplify a part of GAPDH mRNA was used as control. For 
primers used in these experiments see Table S11. 
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Figure legends 
 
Fig. 1. hMTR4 interacts stoichiometrically with the exosome core 
(A) hRRP6-FLAG SILAC co-IP result plotted by relative protein abundance (total 
peptide intensity divided by molecular weight (MW)) out the x-axis and log SILAC 
ratio (intensity of peptides originating from the hRRP6- vs. control-IP) up the y-axis. 
Note disruption of the x-axis to accommodate all detected proteins in the plot. 
Different types of interaction partners are indicated by color coding and relevant 
protein names are displayed. The entire data set is specified in Table S1. The 
asterisk (at hRRP6) indicates the FLAG-tagged bait protein. 
(B) SDS-PAGE analysis of IP eluates from tet-induced (hRRP6-FLAG expressing) 
and un-induced HEK293 cells. Protein band ID’s were achieved by MALDI-TOF MS. 
The migrations of IgG heavy- and light-chains as well as the HSPA1A protein 
contaminant are indicated. 
(C) MS determination of relative levels of the indicated proteins in hRRP41-FLAG IP 
eluates from HEK293 cells depleted for hRRP6 vs. non-depleted cells. The 
calculation is done by MaxQuant (Cox and Mann, 2008), and based on the intensity 
of peptides from label-free experiments. 
 
Fig. 2. Identification of the nuclear exosome targeting (NEXT) complex 
(A) hMTR4-FLAG SILAC co-IP result plotted and labeled as in Fig. 1A. High-
specificity interactors with log SILAC ratio above 0.5 are indicated in orange. Note 
disruption of the x-axis to accommodate all detected proteins in the plot. 
(B) Schematic outline of the two different SILAC purification strategies, ‘mixed 
extracts’ (ME) and ‘mixed beads’ (MB), to assay for dynamics of interactions. IP 
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experiments of differentially labeled samples are either carried out separately and 
mixing beads at the end (MB, left) or by mixing extracts and subjecting this material 
to common bead-binding and elution (ME, right). SILAC ratios that are constant 
between experimental strategies signify stable interactions. 
(C) Interaction dynamics of most prominent hMTR4 binding partners. SILAC ratios 
are displayed for MB (black) and ME (red) experiments. 
(D) ZCCHC8-FLAG co-IP result plotted and labeled as in Fig. 1A. The two groups of 
high-specificity (log SILAC ratio>0.5) and high-abundance (signal 
intensity/MW*106>100) interactors are indicated in orange and blue, respectively. 
Note disruption of the x-axis to accommodate all detected proteins in the plot. 
(E) Interaction dynamics of most prominent ZCCHC8 binding partners displayed as in 
(C). 
(F) The NEXT complex: RBM7-EGFP fusion protein was purified from HEK293 cells 
using stringent conditions (500mM NaCl) and eluate was analyzed by SDS-PAGE. 
The MS-identification of commassie stained bands is indicated. Asterisks indicate 
contaminants. 
 
Fig. 3. Differential nuclear partitioning of human exosome co-factors  
(A, B) Nuclear-localized hMTR4 and hTRF4-2 accumulate in nucleoli. ZCCHC7 
strictly localizes to, and nuclear ZCCHC8 and RBM7 are excluded from, nucleoli. In 
(A), HeLa cells were transiently transfected with plasmids expressing the indicated 
proteins as C-terminal EGFP fusions. 12h post-transfection, protein expression was 
induced with tetracycline for 24h, cells were fixed and proteins were visualized by 
confocal microscopy. Fibrillarin staining served as a nucleolar marker and was 
overlayed with labeling of nuclei by Hoechst stain. In (B), HEK293 Flp-In T-REx cells 
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stably expressing N-terminally EGFP-tagged proteins were analyzed by live cell 
confocal microscopy. Protein expression was induced as above. Cells were 
visualized using phase contrast and overlaid with signal from EGFP fluorescence.  
(C) ZCCHC8 and ZCCHC7 distribute in hDIS3- and hRRP6-containing low and high 
molecular weight glycerol gradient fractions, respectively. Western blotting analysis 
of 5%-40% glycerol gradient fractions of HEK293 cell extract, employing the 
indicated antibodies. Input material corresponding to 5% of the total cell extract  was 
loaded in each of the two outer lanes of the gel. 
 
Fig. 4. Interaction profiles of human putative TRAMP homologs 
(A) Domain comparison of putative TRAMP subunits from H. sapiens, D. 
melanogaster and S. pombe with those of S. cerevisiae TRAMP components. Known 
domains are colored as indicated. For detailed sequence alignments see Fig. S4A-C.  
(B, C) ZCCHC7- and hTRF4-2-FLAG co-IP results plotted and labeled as in Fig. 1A. 
Only here, label-free IP’s of ZCCHC7 and hTRF4-2 were conducted and peptide 
signal intensities were calculated by the label-free algorithm in MaxQuant software 
using normalization to the control (uninduced cell line) IP. Likely due to post-
translational modifications, ZCCHC7 peptides were underrepresented in both MS 
spectra. Note disruption of the x-axes to accommodate all detected proteins in the 
plots. Full label-free datasets are labeled in grey. 
(D) Verification of interactions by western blotting analysis. The hRRP6-, hMTR4-, 
ZCCHC8-, ZCCHC7- and hTRF4-2-FLAG eluates obtained after purification in the 
presence of 100mM, or 500mM, NaCl were probed with anti-hMTR4-, -hRRP6-, -
ZCCHC8-, -ZCCHC7- and -hRRP40-antibodies as indicated. Asterisk denotes band 
corresponding to hRRP6 from previous hybridization. 
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Fig. 5. Substrate preference of NEXT reflects its sub-nuclear distribution 
(A) Western blotting analysis of whole cell extracts showing protein depletion upon 
the indicated siRNA administrations. Top panels: HeLa cells were treated with the 
indicated siRNAs and control cells were treated with EGFP siRNA. Membranes were 
probed using specific antibodies as indicated to the right. Anti-Actin antibody was 
used as a loading control. HEK293 cells expressing EGFP-tagged RBM7 (bottom 
left) or FLAG-tagged hTRF4-2 (bottom right) were treated with the indicated siRNAs. 
In the EGFP-RBM7 experiment, TEL/AML siRNA was used as control. Protein 
depletion was assayed using anti-EGFP or anti-FLAG antibodies as indcated. 
(B) PROMPTs are stabilized in cells depleted for exosome- and NEXT complex-
components. Total RNA harvested from HeLa cells subjected to the indicated siRNA 
transfections were analyzed by dT-primed RT-qPCR using amplicons for the 
indicated PROMPTs; ID numbers from left to right: 40-9, -14, -16, -18, -38, -31, -13, -
52, -33, -2b (Preker et al. 2008; Table S14). Data are displayed as mean values 
normalized to control (EGFP siRNA-treated cells). All data are normalized to GAPDH 
RNA as an internal control. Error bars represent standard deviations from biological 
repeats (n=3). Note disruption of y-axis to accommodate all data in the plot. 
 
Fig. 6. Substrate preference of ZCCHC7 and hTRF4-2 reflects their sub-nuclear 
distributions 
(A) Schematic representation of the 47S rRNA transcript. Boxes indicate the mature 
rRNAs 18S, 5.8S and 28S, which are flanked by the external spacers (ETSs) and 
separated by the internal spacers (ITSs). 
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(B) Schematic outline of the 5’ETS RNA adenylation assay. Adenylated 5’ETS RNAs 
arising from Actinomycin D-induced 47S rRNA degradation are reverse transcribed 
with the indicated dT-adaptor oligo followed by limited PCR using the indicated 
‘5’ETS-1’ and ‘adaptor’ primers. PCR products are subjected to Southern analysis 
using the 5’ETS-2 hybridization probe.  
(C) Adenylation of 5’ETS degradation fragments is compromised upon ZCCHC7 or 
hTRF4-2 depletion. Southern blotting analysis of RT-PCR products derived from total 
RNA harvested from cells subjected to the indicated knock downs and using the 
reagents indicated in (B). A representative experiment from three repeats is shown. 
As an internal control, RT-PCR using GAPDH specific primers was performed. Probe 
signals were quantified, normalized to GAPDH levels and plotted relative to EGFP 
controls. 
(D) hMTR4 and the core exosome are important for 5.8S rRNA 3’end prcessing. 
Total RNA harvested from HeLa cells subjected to the indicated siRNA-mediated 
knock downs was subjected to northern blotting analysis using a radiolabeled ribo-
probe targeting the ITS2 region (A). Mature 5.8S rRNA was visualized using a 
radiolabeled DNA oligo-probe. Probe signals arising from the 3’end extended species 
were quantified and plotted relative to EGFP controls. 
 
Fig. 7. Sub-nuclear distribution of human nuclear exosome co-factors 
Model overview of human nuclear exosome co-factors and their sub-nuclear 
localizations as derived from this study. The dually (nucleolar as well as non-
nucleolar) localized hMTR4 (structure derived from its S. cerevisiae homolog (Weir et 
al., 2010) is centrally positioned and associates with the nuclear exosome (dashed 
arrows). In the non-nucleolar part of the nucleus, hMTR4 forms a stable trimeric 
 35 
complex with ZCCHC8 and RBM7. This NEXT complex is excluded from the nucleoli, 
where hMTR4 instead cooperates with putative TRAMP homologous components 
ZCCHC7 and hTRF4-2. The latter is also present outside nucleoli. 
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Supplementary figure legends 
 
Figure S1 
(A) Western blotting analysis of hRRP6-FLAG SILAC mixed beads (MB) co-IP 
experiment. The analysis shows that the tagged protein was expressed at near 
endogenous level when induced with 30ng/ml of tetracycline. Input and eluate 
fractions were probed with α-RRP6 antibodies. 
(B) Western blotting analysis of whole cell extracts showing hRRP6 depletion 
efficiency in tetracycline-induced cells, used for hRRP41 label-free co-IP. HEK293 
cells were treated with siRNAs against hRRP6 and EGFP (control).  
(C, E) Western blotting verification of hMTR4- and ZCCHC8-FLAG expression levels 
in cells induced with different concentration of tetracycline (top panel). The optimal 
expression conditions (closest to endogenous level, marked in red) were applied for 
subsequent experiments: SILAC mixed beads (MB) and mixed extracts (ME) co-IP 
(bottom panel; Fig. 2A, C), and label-free experiments (Fig. S1D, F ; S2A, B). Input 
and eluate fractions were probed with α-FLAG, and specific α-hMTR4 and α-
ZCCHC8 antibodies, respectively. 
(D, F) hMTR4- and ZCCHC8-FLAG label-free co-IPs performed in low stringent 
conditions (100mM NaCl). Results are plotted and labeled as in Fig. 2A. The entire 
dataset is specified in Table S3. Peptide signal intensities were calculated by the 
label-free algorithm in MaxQuant software, using normalization to the control 
(uninduced cell line) IP. Note disruption of the x-axes to accommodate all detected 
proteins in the plots. Names of high-specificity and high-abundance interactors were 
displayed. Full label-free datasets are labeled in grey. 
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Figure S2 
(A, B) hMTR4 and ZCCHC8-FLAG label-free co-IPs performed in highly stringent 
(500mM) conditions. Results are plotted as in Fig. S1D with only NEXT components 
indicated. The calculations were performed as before (Fig. S1D, F).  
 
Figure S3 
(A) Intracellular localization of C-terminal EGFP-tagged components of the NEXT 
complex: ZCCHC8, RBM7 and hMTR; as well as hTRF4 and ZCCHC7. HEK293 cells 
stably expressing the fusion proteins were subjected to the standard 
immunofluoresce procedure followed by confocal microscopy. Hoechst stained nuclei 
and fibrillarin were overlayed as indicated. 
(B) Nucleolar localization of ZCCHC7 protein in HeLa cells. The cells were subjected 
to α-ZCCHC7 immunostaining, which pattern was then overlaid with phase contrast 
light (left panel - nucleoli are pointed with arrows). Specificity of the ZCCHC7 signal 
was verified by treatment of HeLa cells with siRNA against ZCCHC7 or EGFP 
(control). Similar settings were used for visualizations. 
 
Figure S4  
(A-C) Multiple sequence alignments of yeast Air1p, Trf4p and Mtr4p with their closest 
homologs from human, fly and fission yeast, as determined by using Basic Local 
Alignment Search Tool (BLAST) on protein sequence. All alignments were done 
using the CLC main Main workbench 5.6.1 software, www.clcbio.com. For protein 
accession numbers used in this study see Table S2. 
(D) Western blotting verification of ZCCHC7- and hTRF4-FLAG induction levels in 
label-free co-IPs. Cells were induced with the indicated concentration of tetracycline. 
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Conditions marked in red were chosen for MS analyses. Inputs and eluates were 
probed with α-FLAG and α-ZCCHC7 antibodies (there is no-available reagent to 
detect hTRF4-2).  
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